Stock listing

NASDAQ:LFCR Lifecore Biomedical, Inc. Stock

Home listing (NASDAQ) of Lifecore Biomedical, Inc.

Follow Lifecore Biomedical, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:LFCR

$6.39 USD -0.01 (-0.2%)

Close on Nov 20, 2026

Past year -13.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.37 – $6.39 USDNov 20, 2026
Volume
218,736 sharesNov 20, 2026
Market cap
$242.2M USDAt the close on Nov 20, 2026 · price × 37.91M shares outstanding
52-week range
$3.63 – $8.98 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.47M USDMedian day 229,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Lifecore Biomedical, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LFCR · Home$6.39 USD-0.01 (-0.2%)218,736$6.37$6.39$6.369$6.40Close on Nov 20, 2026
Frankfurt:LDE€5.65 EUR-0.10 (-1.7%)—€5.65€5.65€5.65€5.75Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LFCR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.39-0.01-0.2%$6.37$6.39$6.369218,736
$6.40+0.01+0.2%$6.40$6.405$6.39147,540
$6.39-0.025-0.4%$6.41$6.42$6.39181,969
$6.415-0.005-0.1%$6.41$6.42$6.4065,923
$6.42+0.02+0.3%$6.40$6.42$6.3883,094
$6.400.000.0%$6.38$6.40$6.38108,889
$6.40+0.03+0.5%$6.37$6.40$6.37149,717
$6.370.000.0%$6.37$6.385$6.37369,580
$6.37+0.01+0.2%$6.36$6.39$6.36142,904
$6.36-0.04-0.6%$6.38$6.39$6.36780,492
$6.40-0.04-0.6%$6.45$6.45$6.375700,056
$6.44+0.02+0.3%$6.44$6.45$6.41270,724
$6.42+0.03+0.5%$6.41$6.44$6.405297,915
$6.39-0.01-0.2%$6.40$6.42$6.375483,332
$6.40-0.12-1.8%$6.48$6.499$6.3151,023,939
$6.52+0.01+0.2%$6.52$6.52$6.47240,905
$6.51+0.07+1.1%$6.44$6.51$6.43365,155
$6.440.000.0%$6.36$6.44$6.36441,609
$6.44+0.04+0.6%$6.41$6.44$6.40436,363
$6.40+0.03+0.5%$6.36$6.40$6.36224,000
$6.370.000.0%$6.37$6.39$6.36178,700
$6.370.000.0%$6.40$6.40$6.36270,400
$6.37-0.02-0.3%$6.38$6.40$6.37588,300
$6.39+0.01+0.2%$6.38$6.42$6.38229,900
$6.38-0.06-0.9%$6.42$6.44$6.381,424,600
$6.44+0.02+0.3%$6.44$6.48$6.42233,400
$6.420.000.0%$6.40$6.44$6.40268,000
$6.42-0.02-0.3%$6.46$6.46$6.40590,600
$6.44-0.01-0.2%$6.45$6.46$6.43312,000
$6.45+0.02+0.3%$6.43$6.46$6.42387,100
$6.43-0.01-0.2%$6.43$6.46$6.42492,100
$6.44-0.01-0.2%$6.45$6.48$6.431,720,300
$6.45-0.07-1.1%$6.51$6.54$6.441,232,100
$6.52-0.02-0.3%$6.54$6.57$6.51840,600
$6.54+0.01+0.2%$6.55$6.55$6.53504,500
$6.53-0.05-0.8%$6.57$6.58$6.53707,000
$6.58-0.01-0.2%$6.55$6.61$6.54970,200
$6.59+0.07+1.1%$6.53$6.61$6.51685,300
$6.52+2.32+55.2%$6.52$6.65$6.404,005,300
$4.20-0.09-2.1%$4.27$4.39$4.1270,500
$4.29-0.11-2.5%$4.41$4.41$4.2197,200
$4.40-0.10-2.2%$4.45$4.49$4.39205,200
$4.50+0.02+0.4%$4.52$4.52$4.3790,400
$4.48+0.02+0.4%$4.48$4.51$4.22170,700
$4.460.000.0%$4.44$4.55$4.33280,800
$4.46+0.30+7.2%$4.22$4.48$4.16144,700
$4.16+0.02+0.5%$4.11$4.33$4.1094,900
$4.14-0.11-2.6%$4.21$4.23$4.1376,100
$4.25+0.13+3.2%$4.12$4.28$4.02110,700
$4.12+0.03+0.7%$4.14$4.19$4.06159,500
$4.090.000.0%$4.00$4.27$4.00199,000
$4.09-0.22-5.1%$4.29$4.31$4.03264,800
$4.31-0.09-2.0%$4.36$4.40$4.28185,700
$4.40+0.05+1.1%$4.35$4.60$4.29277,400
$4.35-0.39-8.2%$4.69$4.69$4.34121,300
$4.74+0.35+8.0%$4.42$4.80$4.42235,900
$4.39-0.07-1.6%$4.45$4.49$4.3581,300
$4.46-0.08-1.8%$4.50$4.61$4.4588,000
$4.540.000.0%$4.54$4.65$4.47132,000
$4.54-0.11-2.4%$4.64$4.70$4.53122,300
$4.65+0.01+0.2%$4.64$4.76$4.5586,400
$4.64+0.09+2.0%$4.55$4.83$4.55113,413
$4.55+0.01+0.2%$4.55$4.59$4.37101,453
$4.54+0.02+0.4%$4.58$4.70$4.5090,600
$4.52+0.06+1.3%$4.42$4.57$4.32121,500
Ticker
NASDAQ:LFCR
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Lifecore Biomedical, Inc. news

Lifecore Biomedical, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
28 in the last 12 months · 84 in all · newest Nov 4, 2026 · oldest 2019
Calls
19 calls with a replay · 19 with a transcript · latest Aug 5, 2026
Decks
17 decks · latest Sep 28, 2026

Where Lifecore Biomedical, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LFCR · Home listing · This pageNASDAQUnited StatesUSD
gettex:LDEgettexGermanyEUR
Lang & Schwarz:899376Lang & SchwarzGermanyEUR
LS Exchange:899376LS ExchangeGermanyEUR
BOATS:LFCRBOATSUnited StatesUSD
Frankfurt:LDEFrankfurtGermanyEUR
Dusseldorf:LDEDusseldorfGermanyEUR
Stuttgart:LDEStuttgartGermanyEUR
Tradegate:LDETradegateGermanyEUR

Valuation

EV/sales 2.9× against a median of 4.0×: 5th lowest of 10 Diagnostics & research services companies shown. Statements: Year to May 31, 2026 · balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$380.1M USD
P/E
Loss
EV/sales
2.9×
EV/EBITDA
46.1×
Price/book
Negative equity
Gross margin
31.4%
Operating margin
−1.0%
Net margin
−23.8%
Debt to equity
Negative equity
Beta vs S&P 500
0.51

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Lifecore Biomedical, Inc. · NASDAQ:LFCRUS$242.2MUS$380.1Mn/a2.9×46.1×n/a−23.8%n/a0.51
Eurobio-Scientific SA · EURONEXT:ALERSUS$291.7MUS$279.0M54.6×1.5×7.8×1.4×2.9%0.1×n/a
Jinan High-tech Development Co., Ltd. Class A · SSE:600807US$281.5MUS$159.8Mn/a2.6×n/a7.2×−51.6%0.1×n/a
Dirui Industrial Co., Ltd. Class A · SZSE:300396US$270.6MUS$206.0Mn/a1.4×n/a1.2×−18.0%0.1×n/a
Nautilus Biotechnology, Inc. · NASDAQ:NAUTUS$270.0MUS$183.5Mn/an/an/a2.3×n/a0.0×1.47
Shanghai Hile Bio-technology Co Ltd Class A · SSE:603718US$256.2MUS$222.0Mn/a5.3×n/a1.9×−111.9%0.1×n/a
Jiangsu Cowin Biotech Co., Ltd. Class A · SSE:688426US$250.1MUS$138.3Mn/a4.0×n/a1.3×−35.4%0.0×n/a
OraSure Technologies, Inc. · NASDAQ:OSURUS$238.9MUS$102.3Mn/a0.9×n/a0.8×−41.7%0.0×1.21
Shanghai Rendu Biotechnology Co., Ltd. Class A · SSE:688193US$216.7MUS$100.3M64.7×4.2×n/a1.6×13.9%0.0×n/a
Median Technologies · EURONEXT:ALMDTUS$214.8MUS$176.5Mn/a6.9×n/an/a−145.8%n/an/a
Tomocube, Inc. · KRX:475960US$208.3MUS$187.2Mn/a16.6×n/a7.4×−16.1%0.0×n/a
Median of the othersUS$253.1MUS$180.0M59.7×4.0×7.8×1.6×−35.4%0.0×1.34

Forecasts

5 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
6.28 USD · Analysts' mean
EPS, year to Dec 2026
-1.83 · 1 analyst
Revenue, year to Dec 2026
120.4M · 2 analysts

Team and board

Officers

OfficerRole
Paul JosephsChief Executive Officer
Ryan D. LakeChief Financial Officer
Tom SalusChief Legal and Administration Officer
Jackie KleckerExecutive Vice President, Quality and Development Services
Thomas GuldagerSr. Vice President, Operations
Mark DaFonsecaChief Commercial Officer

Board

DirectorRole
Paul JosephsChief Executive Officer

Events

Calls

CallWhenStatus
Lifecore Biomedical (NASDAQ:LFCR) Q2 2026 Earnings CallWed, Aug 05, 2026 · 8:00 AM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q1 2026 Earnings CallWed, May 06, 2026 · 8:00 AM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q4 2025 Earnings CallMon, Mar 16, 2026 · 8:30 AM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q3 2025 Earnings CallThu, Nov 06, 2025 · 4:30 PM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q4 2024 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q3 2024 Earnings CallThu, Apr 03, 2025 · 4:30 PM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q2 2024 Earnings CallThu, Jan 02, 2025 · 4:30 PM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q1 2024 Earnings CallFri, Oct 04, 2024 · 8:30 AM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q4 2023 Earnings CallThu, Aug 31, 2023 · 8:30 AM ETReplay
Lifecore Biomedical (NASDAQ:LFCR) Q3 2023 Earnings CallThu, Jun 01, 2023 · 8:30 AM ETReplay
All 19 calls
CallWhenStatus
Landec Corporation (LNDC) Q1 2023 Earnings CallWed, Oct 05, 2022 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q4 2022 Earnings CallWed, Aug 10, 2022 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q3 2022 Earnings CallTue, Apr 05, 2022 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q2 2022 Earnings CallWed, Jan 05, 2022 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q1 2022 Earnings CallWed, Sep 29, 2021 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q4 2021 Earnings CallWed, Jul 28, 2021 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q3 2021 Earnings CallWed, Apr 07, 2021 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q2 2021 Earnings CallWed, Jan 06, 2021 · 5:00 PM ETReplay
Landec Corporation (LNDC) Q1 2021 Earnings CallTue, Oct 06, 2020 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q1 2027Nov 4, 2026 · Before open+0.3%
Q4 2026Aug 5, 2026 · Before open+2.1%
Q3 2026Apr 7, 2026 · After close+3.2%
Q2 2026Jan 1, 2026−5.4%
Q1 2026Nov 6, 2025 · After close+3.5%
Q4 2025Aug 7, 2025 · After close−6.7%
Q3 2025Apr 3, 2025 · After close−22.3%
Q2 2025Jan 2, 2025 · After close+14.4%
Q1 2025Oct 4, 2024 · Before open+14.3%
Q4 2024Aug 26, 2024 · After close−25.2%
All 20 quarters
QuarterResultsShare move
Q2 2024Dec 29, 2023 · Before open+0.2%
Q1 2024Nov 14, 2023 · Before open+6.7%
Q4 2023Aug 31, 2023 · Before open−11.8%
Q3 2023Mar 16, 2023 · After close−67.3%
Q2 2023Feb 27, 2023 · After close+0.5%
Q1 2023Oct 6, 2022 · Before open+0.1%
Q4 2022Aug 10, 2022 · After close+2.6%
Q3 2022Apr 5, 2022 · After close−6.0%
Q2 2022Jan 5, 2022 · After close+1.0%
Q1 2022Sep 29, 2021 · After close−10.3%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (September 2026)Merger or acquisition11 slidesSep 28, 2026
Investor Presentation (August 2026)Investor deck23 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings23 slidesMay 6, 2026
Transition period en Earnings PresentationEarnings25 slidesMar 16, 2026
Q4 2025 Earnings PresentationEarnings20 slidesMar 16, 2026
FY2025 Earnings PresentationEarnings33 slidesNov 6, 2025
Q3 2025 Earnings PresentationEarnings33 slidesNov 6, 2025
Jefferies Global Healthcare Conference 2025Conference22 slidesNovember 2025
Investor Presentation (August 2025)Investor deck33 slidesAug 12, 2025
Q3 FY2025 Earnings PresentationEarnings26 slidesApr 3, 2025
All 17 decks
DeckKindSlidesDate
Investor Presentation (January 2025)Investor deck27 slidesJan 2, 2025
Investor Day (November 2024)Investor day39 slidesNov 21, 2024
Investor Presentation (October 2024)Investor deck22 slidesOct 4, 2024
Investor Presentation (April 2024)Investor deck29 slidesApr 1, 2024
FY2023 Earnings PresentationEarnings5 slidesMar 20, 2024
Landec Corp \ca\ — Investor Presentation (August 2022)Investor deck24 slidesAug 10, 2022
Landec Corp \ca\ — Investor Presentation (January 2022)Investor deck22 slidesJan 10, 2022

Open Decks

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue129.5M128.9M128.3M103.3M111.3M100.9M160.1M557.6M524.2M469.8M
Cost of revenue88.9M88.6M86.4M75.3M72.2M61.9M120.7M476.6M445.9M390.6M
Gross profit40.6M40.3M41.9M28.0M39.1M38.9M39.4M81.0M78.3M79.2M
Research and development8.50M8.26M8.57M8.74M7.84M6.68M7.58M11.5M12.8M9.47M
Selling, general and administrative44.0M40.5M39.0M34.7M27.7M40.7M62.1M52.0M52.5M
Operating income-1.26M-17.2M-8.84M-21.8M-11.8M-8.82M-25.9M5.47M13.6M14.7M
Depreciation and amortization9.50M8.03M7.95M13.2M18.1M19.9M18.8M15.2M12.4M10.7M
EBITDA8.24M-9.22M-890.0K-8.62M6.27M11.0M-7.04M20.7M26.0M25.3M
Interest expense2.21M22.2M18.1M17.6M15.6M8.93M4.65M5.23M1.95M1.83M
Income before tax-30.2M-38.7M9.51M-63.9M-20.7M-29.8M-30.6M3.64M16.4M14.2M
Income tax577.7K43.0K183.0K308.0K-5.21M-6.35M-8.77M1.52M-9.36M4.04M
Net income-30.8M-38.7M12.0M-99.6M-116.7M-32.3M-38.2M411.0K24.8M10.6M
Earnings per share, basic-0.82-1.270.39-3.32-3.97-1.10-1.310.010.900.39
Earnings per share, diluted-1.270.33-3.32-3.97-1.10-1.310.010.890.38

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents17.5M8.27M8.46M19.1M991.0K763.0K360.0K1.08M2.90M6.00M
Receivables33.8M43.7M31.2M29.0M38.3M31.6M76.2M69.6M53.9M45.9M
Inventory29.1M32.3M40.0M40.8M36.0M33.9M66.3M54.1M31.8M23.6M
Current assets82.3M85.7M81.0M93.9M116.7M145.3M157.1M133.0M97.1M81.3M
Property, plant and equipment129.0M149.2M134.4M118.7M107.1M192.3M200.0M159.6M133.2M
Goodwill13.9M13.9M13.9M13.9M13.9M13.9M33.9M76.7M54.5M54.5M
Total assets232.2M239.3M254.0M253.5M274.7M501.9M293.5M519.1M404.7M358.6M
Accounts payable5.84M8.22M16.3M22.1M13.0M11.6M51.6M54.0M34.7M24.5M
Current liabilities23.6M30.2M38.9M39.3M176.6M101.9M164.4M137.1M88.4M51.5M
Long-term debt135.6M127.0M100.8M84.3M0164.9M101.4M87.2M37.4M42.3M
Total debt142.6M130.4M124.7M84.8M98.2M164.9M112.9M97.0M42.3M47.2M
Total liabilities246.4M191.9M200.1M218.5M186.9M299.9M310.3M248.9M152.1M130.5M
Shareholders' equity-14.2M1.34M11.3M-4.23M87.8M201.9M229.8M270.1M252.6M226.6M
Shares outstanding37.4M37.0M30.6M30.3M29.5M29.3M29.2M29.1M27.7M27.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations12.6M-206.0K257.0K-17.4M-22.6M16.5M-17.0M16.0M19.8M29.8M
Capital spending-6.34M-13.4M-18.4M-29.9M-26.2M-19.3M-12.2M-44.7M-33.6M-23.0M
Free cash flow6.23M-13.6M-18.1M-52.5M-48.8M-2.79M-29.3M-28.7M-13.8M6.83M
Cash from investing-1.63M-6.42M-18.4M-4.81M80.0M-12.3M-23.9M-96.8M-35.6M-25.4M
Cash from financing-1.11M6.42M7.51M39.7M-57.0M-3.42M40.0M79.0M13.3M-8.80M
Dividends paid-3.08M-274.0K-212.0K-700.0K
Share buybacks-1.94M-152.0K-789.0K-405.0K-212.0K-700.0K-1.48M-434.0K
Change in cash-197.0K-197.0K-10.6M17.4M348.0K742.0K-912.0K-1.75M-2.52M-4.38M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
DEFM14ANov 13, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 5, 2026Meeting noticeSEC
8-K · Current reportNov 5, 2026Current reportSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
PREM14AOct 30, 2026Other filingsSEC
8-K · Current reportOct 20, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 29, 2026Big-stake noticeSEC
8-K · Current reportSep 29, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13D/A · Big-stake notice, amendedSep 28, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialSep 28, 2026Meeting noticeSEC
8-K · Current reportSep 28, 2026Material contractSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 29, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 2, 2026Big-stake noticeSEC
8-K · Current reportJul 2, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 2, 2026Big-stake noticeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
8-K · Current reportJun 5, 2026Management or board changeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 27, 2026Big-stake noticeSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
10-KT · Transition reportMar 16, 2026Annual reportSEC
8-K · Current reportMar 16, 2026ResultsSEC
8-K · Current reportMar 5, 2026Current reportSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJan 21, 2026Big-stake noticeSEC
8-K · Current reportJan 16, 2026Management or board changeSEC
8-K · Current reportNov 17, 2025Current reportSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
8-K · Current reportOct 31, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveOct 1, 2025Other filingsSEC
424B3 · ProspectusSep 30, 2025Offer documentSEC
8-K · Current reportSep 26, 2025Management or board changeSEC
CORRESP · Letter to the SECSep 26, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 25, 2025Other filingsSEC
S-3 · Registration statementSep 22, 2025Offer documentSEC
DEF 14A · Proxy statementSep 18, 2025Meeting noticeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
8-K · Current reportAug 18, 2025Current reportSEC
8-K · Current reportAug 12, 2025Current reportSEC
S-8 · Registration statement for employee plansAug 7, 2025Offer documentSEC
10-K · Annual reportAug 7, 2025Annual reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
8-K · Current reportJul 18, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeJul 17, 2025Big-stake noticeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
4 · Change in ownershipJul 10, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 29, 2025Big-stake noticeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 7, 2025Insider tradeSEC
8-K · Current reportApr 16, 2025Management or board changeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
3 · Initial statement of ownershipApr 16, 2025Insider tradeSEC
8-K · Current reportApr 10, 2025Meeting outcomeSEC
10-Q · Quarterly reportApr 3, 2025Quarterly reportSEC
8-K · Current reportApr 3, 2025ResultsSEC
DEF 14A · Proxy statementFeb 27, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2025Big-stake noticeSEC
PRE 14A · Preliminary proxy statementJan 21, 2025Meeting noticeSEC
DEFA14A · Additional proxy materialJan 17, 2025Meeting noticeSEC
8-K · Current reportJan 17, 2025Current reportSEC
4 · Change in ownershipJan 8, 2025Insider tradeSEC
8-K · Current reportJan 7, 2025Current reportSEC
10-Q · Quarterly reportJan 2, 2025Quarterly reportSEC
8-K · Current reportJan 2, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 26, 2024Big-stake noticeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
8-K · Current reportNov 26, 2024Material contractSEC
8-K · Current reportNov 21, 2024Current reportSEC
144 · Notice of proposed saleNov 20, 2024Other filingsSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
8-K · Current reportNov 8, 2024Meeting outcomeSEC
144 · Notice of proposed saleOct 31, 2024Other filingsSEC
4 · Change in ownershipOct 29, 2024Insider tradeSEC
424B3 · ProspectusOct 23, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 23, 2024Other filingsSEC
CORRESP · Letter to the SECOct 18, 2024Other filingsSEC
UPLOAD · Letter from the SECOct 18, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveOct 16, 2024Other filingsSEC
S-8 · Registration statement for employee plansOct 10, 2024Offer documentSEC
S-8 · Registration statement for employee plansOct 10, 2024Offer documentSEC
S-1 · Registration statementOct 10, 2024Offer documentSEC
POS AM · Amendment to an effective registrationOct 10, 2024Offer documentSEC
4 · Change in ownershipOct 7, 2024Insider tradeSEC
4 · Change in ownershipOct 7, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedOct 7, 2024Big-stake noticeSEC
144 · Notice of proposed saleOct 7, 2024Other filingsSEC
10-Q · Quarterly reportOct 4, 2024Quarterly reportSEC
8-K · Current reportOct 4, 2024ResultsSEC
DEF 14A · Proxy statementSep 23, 2024Meeting noticeSEC
8-K · Current reportSep 23, 2024Management or board changeSEC
144 · Notice of proposed saleSep 20, 2024Other filingsSEC
4/A · Change in ownership, amendedSep 16, 2024Insider tradeSEC
8-K · Current reportSep 12, 2024Current reportSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 5, 2024Insider tradeSEC
8-K · Current reportAug 29, 2024Management or board changeSEC
8-K · Current reportAug 26, 2024ResultsSEC
10-K · Annual reportAug 26, 2024Annual reportSEC
4 · Change in ownershipAug 22, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 22, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 21, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 21, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 21, 2024Insider tradeSEC
8-K · Current reportAug 21, 2024Management or board changeSEC
NT 10-K · Late filing noticeAug 12, 2024Explanation requestSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
DEFA14A · Additional proxy materialAug 9, 2024Meeting noticeSEC
8-K · Current reportJul 24, 2024Management or board changeSEC
DEF 14A · Proxy statementJul 19, 2024Meeting noticeSEC
8-K · Current reportJul 12, 2024Current reportSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
4 · Change in ownershipJul 10, 2024Insider tradeSEC
PRE 14A · Preliminary proxy statementJul 8, 2024Meeting noticeSEC
SC 13D/A · Big-stake notice, amendedJul 5, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJul 1, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJul 1, 2024Big-stake noticeSEC
8-K · Current reportJul 1, 2024Material contractSEC
UPLOAD · Letter from the SECJun 13, 2024Other filingsSEC
SC 13D/A · Big-stake notice, amendedJun 11, 2024Big-stake noticeSEC
8-K · Current reportJun 7, 2024Current reportSEC
CORRESP · Letter to the SECJun 7, 2024Other filingsSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 22, 2024Insider tradeSEC
8-K · Current reportMay 22, 2024Management or board changeSEC
SC 13D/A · Big-stake notice, amendedMay 20, 2024Big-stake noticeSEC
8-K · Current reportMay 16, 2024Current reportSEC
8-K · Current reportMay 14, 2024Material contractSEC
UPLOAD · Letter from the SECMay 13, 2024Other filingsSEC
8-K · Current reportMay 8, 2024Material contractSEC
8-K · Current reportMay 7, 2024Management or board changeSEC
8-K · Current reportApr 30, 2024Current reportSEC
8-K · Current reportApr 19, 2024Current reportSEC
NT 10-Q · Late filing noticeApr 8, 2024Explanation requestSEC
8-K · Current reportApr 1, 2024ResultsSEC
8-K · Current reportMar 26, 2024Current reportSEC
8-K · Current reportMar 20, 2024Management or board changeSEC
8-K · Current reportMar 20, 2024ResultsSEC
10-K · Annual reportMar 19, 2024Annual reportSEC
SC 13D/A · Big-stake notice, amendedFeb 29, 2024Big-stake noticeSEC
8-K · Current reportFeb 16, 2024Current reportSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipJan 22, 2024Insider tradeSEC
8-K · Current reportJan 12, 2024Current reportSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
NT 10-Q · Late filing noticeJan 10, 2024Explanation requestSEC
8-K · Current reportJan 5, 2024Material contractSEC
SC 13D/A · Big-stake notice, amendedJan 4, 2024Big-stake noticeSEC
8-K · Current reportNov 20, 2023Current reportSEC
8-K · Current reportOct 31, 2023Current reportSEC
8-K · Current reportOct 18, 2023Current reportSEC

This page holds 200 of 1,005 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Lifecore Biomedical, Inc.’s releases · as of Oct 28, 2026

Common shares
37,905,846
Fully diluted
37,905,846

Fully diluted

LineSharesAs of
Common shares37,905,846Oct 28, 2026

Share count over time

CountShares
Oct 28, 202637,905,846
Aug 5, 202637,477,386

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Wynnefield Capital Inc4.87M12.8%US$32MSep 30, 2026
Legion Partners Asset Management, LLC4.48M11.8%US$29.5MSep 30, 2026
325 Capital LLC2.9M7.6%US$19.1MSep 30, 2026
Greenhaven Road Investment Management, L.P.2.87M7.6%US$18.9MSep 30, 2026
BlackRock2.02M5.3%US$13.3MSep 30, 2026
Vanguard1.74M4.6%US$11.4MSep 30, 2026
Geode Capital849K2.2%US$5.59MSep 30, 2026
Morgan Stanley738K1.9%US$4.85MSep 30, 2026
State Street638K1.7%US$4.2MSep 30, 2026
Quinn Opportunity Partners LLC539K1.4%US$3.55MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
DCF Advisers, LLC377K0.99%US$2.48MSep 30, 2026
Wittenberg Investment Management, Inc.305K0.81%US$2.01MSep 30, 2026
Citadel285K0.75%US$1.88MSep 30, 2026
Marshall Wace, LLP259K0.68%US$1.71MSep 30, 2026
Northern Trust249K0.66%US$1.64MSep 30, 2026
Allspring Global Investments Holdings, LLC169K0.44%US$1.1MSep 30, 2026
Renaissance Technologies163K0.43%US$1.07MSep 30, 2026
LPL Financial LLC145K0.38%US$954KSep 30, 2026
Susquehanna128K0.34%US$841KSep 30, 2026
Goldman Sachs125K0.33%US$826KSep 30, 2026
Tocqueville Asset Management L.P.96,5000.25%US$635KSep 30, 2026
CWC Advisors, LLC.86,7570.23%US$571KSep 30, 2026
Gamco Investors, Inc. Et Al83,8000.22%US$551KSep 30, 2026
Corient Private Wealth LP78,4880.21%US$516KSep 30, 2026
XTX Topco Ltd75,4550.20%US$496KSep 30, 2026
Schwab69,7200.18%US$459KSep 30, 2026
BNY67,2720.18%US$443KSep 30, 2026
Millennium62,5550.17%US$412KSep 30, 2026
Gsa Capital Partners LLP62,1270.16%US$409KSep 30, 2026
UBS55,2370.15%US$363KSep 30, 2026
Nuveen55,0670.15%US$362KSep 30, 2026
Acadian Asset Management LLC52,9070.14%US$344KSep 30, 2026
Bridgeway Capital Management, LLC51,8000.14%US$341KSep 30, 2026
Hrt Financial LP48,3700.13%US$318KSep 30, 2026
Empowered Funds, LLC46,9000.12%US$309KSep 30, 2026
Bank of America40,1580.11%US$264KSep 30, 2026
BNP Paribas39,8830.11%US$262KSep 30, 2026
AQR Capital Management LLC36,2700.10%US$239KSep 30, 2026
Steward Partners Investment Advisory, LLC34,0850.09%US$224KSep 30, 2026
Rhumbline Advisers33,3140.09%US$219KSep 30, 2026
Qube Research & Technologies Ltd24,6560.07%US$162KSep 30, 2026
R Squared Ltd23,3800.06%US$154KSep 30, 2026
Squarepoint Ops LLC23,2750.06%US$153KSep 30, 2026
T. Rowe Price22,5600.06%US$149KSep 30, 2026
DWS22,4020.06%US$147KSep 30, 2026
Mraz, Amerine & Associates, Inc.22,1600.06%US$146KSep 30, 2026
Virtu Financial LLC19,4840.05%US$128KSep 30, 2026
JPMorgan18,6530.05%US$123KSep 30, 2026
Diversified Trust Co18,1460.05%US$119KSep 30, 2026
Sei Investments Co17,4230.05%US$115KSep 30, 2026

This page holds 50 of 101 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund822K2.2%US$4.32MJun 30, 2026
iShares Russell 2000 ETF729K1.9%US$3.83MJun 30, 2026
Vanguard Extended Market Index Fund435K1.1%US$2.29MJun 30, 2026
Fidelity Small Cap Index Fund303K0.80%US$1.34MJul 31, 2026
iShares Russell 2000 Value ETF240K0.63%US$1.26MJun 30, 2026
Fidelity Extended Market Index Fund198K0.52%US$996KMay 31, 2026
Vanguard Russell 2000 Index Fund142K0.38%US$715KMay 31, 2026
Allspring Small Company Value Portfolio135K0.36%US$597KJul 31, 2026
iShares Micro-Cap ETF94,9030.25%US$498KJun 30, 2026
1290 VT GAMCO Small Company Value Portfolio78,0000.21%US$410KJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fidelity Total Market Index Fund69,9360.18%US$351KMay 31, 2026
Schwab Small-Cap Index Fund69,0970.18%US$305KJul 31, 2026
Ultra-Small Company Market Fund56,9000.15%US$299KJun 30, 2026
Fidelity Series Total Market Index Fund56,2140.15%US$282KMay 31, 2026
Master Small Cap Index Series43,3640.11%US$228KJun 30, 2026
Fidelity Small Cap Value Index Fund36,7370.10%US$193KJun 30, 2026
Nuveen Small Cap Blend Index Fund35,8500.09%US$158KJul 31, 2026
EQ/2000 Managed Volatility Portfolio32,4070.09%US$170KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund30,9220.08%US$162KJun 30, 2026
iShares Russell 2000 Growth ETF28,2130.07%US$148KJun 30, 2026
Fidelity Nasdaq Composite Index Fund22,3360.06%US$112KMay 31, 2026
Fidelity ZERO Total Market Index Fund20,0780.05%US$88,745Jul 31, 2026
Vanguard Russell 2000 Growth Index Fund19,3210.05%US$96,991May 31, 2026
LVIP State Street Small-Cap Index Fund19,3000.05%US$101KJun 30, 2026
Schwab Total Stock Market Index Fund18,4270.05%US$81,447Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund15,7400.04%US$82,635Jun 30, 2026
Vanguard Balanced Index Fund15,3660.04%US$80,672Jun 30, 2026
Fidelity ZERO Extended Market Index Fund13,9720.04%US$61,756Jul 31, 2026
Global X Russell 2000 ETF13,4940.04%US$59,643Jul 31, 2026
Small Cap Index Fund12,0250.03%US$63,131Jun 30, 2026
Small Cap Index Fund11,2210.03%US$56,329May 31, 2026
State Street Small/Mid Cap Equity Index Portfolio9,6000.03%US$50,400Jun 30, 2026
MetLife Russell 2000 Index Portfolio9,3140.02%US$48,899Jun 30, 2026
EQ/Small Company Index Portfolio7,9900.02%US$41,948Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio7,6080.02%US$39,942Jun 30, 2026
1290 VT Micro Cap Portfolio6,3960.02%US$33,579Jun 30, 2026
Fidelity Flex Small Cap Index Fund6,2160.02%US$27,475Jul 31, 2026
Small-Cap Index Portfolio6,1030.02%US$32,041Jun 30, 2026
Vanguard Russell 2000 Value Index Fund5,8760.02%US$29,498May 31, 2026
NVIT Small Cap Index Fund4,7900.01%US$25,148Jun 30, 2026
DWS Small Cap Index VIP4,2260.01%US$22,187Jun 30, 2026
Voya RussellTM Small Cap Index Portfolio4,1910.01%US$22,003Jun 30, 2026
BlackRock Small Cap Index V.I. Fund4,0150.01%US$21,079Jun 30, 2026
1290 VT Small Cap Value Portfolio4,0130.01%US$21,068Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund4,0020.01%US$21,011Jun 30, 2026
Victory Extended Market Index Fund3,9510.01%US$17,463Jul 31, 2026
Bridge Builder Small/Mid Cap Value Fund3,8670.01%US$20,302Jun 30, 2026
T. Rowe Price Small-Cap Index Fund3,629<0.01%US$19,052Jun 30, 2026
Gabelli Global Mini Mites Fund3,500<0.01%US$18,375Jun 30, 2026
iShares Russell Small/Mid-Cap Index Fund3,493<0.01%US$15,439Jul 31, 2026

This page holds 50 of 91 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Legion Partners Asset Management, LLC17.30%6.99MSep 27, 2026Schedule 13D
Nelson Obus14.30%5.51MSep 27, 2026Schedule 13D
22NW Fund, LP6.74%2.71MJun 30, 2026Schedule 13D
BlackRock, Inc.5.40%2.01MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jason M. Aryeh
Other companies: Orchestra BioMed Holdings, Inc. (Director · Since at least Jan 26, 2023); Anebulo Pharmaceuticals, Inc. (Board Member · Since at least May 6, 2021); Ligand Pharmaceuticals Incorporated (Director · Since at least May 30, 2007); Immunomedics Inc (Director · Jan 8, 2017 – Jan 8, 2017 · Past); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 19, 2017 · Past); Novelion Therapeutics Inc (Director · Jun 4, 2012 – May 15, 2017 · Past); Myrexis Inc (Director · Oct 19, 2011 – Jun 18, 2012 · Past); Vaxart, Inc. (Director · May 18, 2007 – May 25, 2011 · Past)
Director · Since at least Aug 15, 2024
Craig Barbarosh
Other companies: Evolent Health, Inc (Director · Since at least Dec 21, 2020); Sabra Health Care REIT, Inc. (Director · Since at least Nov 5, 2010); ModivCare Inc (Director · Dec 23, 2024 – Dec 23, 2024 · Past); Aratana Therapeutics Inc (Director · May 18, 2018 – Jul 18, 2019 · Past); Bazaarvoice Inc (Director · Sep 27, 2017 – Feb 1, 2018 · Past); Timber Pharmaceuticals Inc (Director · Jan 26, 2016 – Jul 21, 2016 · Past); Nextgen Healthcare Inc (Director · Sep 17, 2009 – Nov 9, 2023 · Past)
Director · Oct 15, 2019 – Jul 8, 2024 · Past
Catherine Angell Sohn
Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Axcella Health Inc (Director · Aug 21, 2019 – May 19, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Palisade Bio, Inc. (Director · Jan 13, 2014 – Jul 1, 2015 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past)
Director · Nov 13, 2012 – Jun 4, 2022 · Past
Joshua Schechter
Other companies: Barnwell Industries, Inc. (Director · Since at least Nov 28, 2025); Pursuit Attractions and Hospitality, Inc. (Director · Since at least Apr 11, 2015); Bed Bath & Beyond, Inc. (Director · May 29, 2019 – Jan 20, 2023 · Past); Genesco Inc. (Director · Apr 24, 2018 – Jun 27, 2018 · Past); Support.com Inc (Director · Jun 28, 2016 – Sep 14, 2021 · Past); The Pantry Inc (Director · Mar 13, 2014 – Mar 16, 2015 · Past)
Director · Since at least Oct 14, 2020
Christopher S Kiper
Other companies: NN, Inc. (Director · Since at least Jan 16, 2026); Clear Channel Outdoor Holdings, Inc. (Director · Since at least Jan 31, 2024); Momentive Global Inc (Director · Mar 1, 2022 – May 31, 2023 · Past); CIBER Inc (Director · Feb 3, 2017 – Feb 3, 2017 · Past); L.B. Foster Company (Director · Sep 14, 2016 – Jun 30, 2017 · Past)
Director · Since at least Jan 9, 2023
Nelson Obus
Other companies: Williams Industrial Services Group Inc (Director · Jun 27, 2016 – Feb 2, 2023 · Past); Jason Industries Inc (Director · Jul 30, 2015 – Jul 1, 2019 · Past); Breeze-Eastern Corp (Director · Feb 20, 2014 – Jan 4, 2016 · Past); Gilman Ciocia Inc (Director · Oct 3, 2008 – Oct 31, 2011 · Past); Layne Christensen Company (Director · Jan 1, 2006 – Jun 14, 2018 · Past)
Director · Since at least Oct 12, 2018
Andrew Kenneth William Powell
Other companies: ARS Pharmaceuticals, Inc. (Director · Dec 3, 2020 – Jun 10, 2022 · Past); Synthorx Inc (Director · Dec 19, 2018 – Jan 23, 2020 · Past); Aclaris Therapeutics, Inc. (Director · May 16, 2018 – Jun 1, 2024 · Past)
Director · Oct 12, 2018 – Jun 4, 2022 · Past
Jeffrey L. Edwards
Other companies: Bio-Rad Laboratories, Inc. (Director · Since at least Apr 25, 2017); Kyntra Bio, Inc. (Director · Since at least Oct 28, 2015); Clearside Biomedical Inc (Director · Sep 26, 2018 – Jun 20, 2024 · Past)
Director · Oct 14, 2020 – Jul 8, 2024 · Past
Matthew E. Korenberg
Other companies: Palvella Therapeutics, Inc. (Chief Financial Officer · Since at least Dec 13, 2024); AIxCrypto Holdings, Inc. (Director · May 22, 2020 – Jul 11, 2022 · Past); Ligand Pharmaceuticals Incorporated (President & COO · Aug 6, 2015 – Sep 20, 2024 · Past)
Director · Since at least Aug 15, 2024
Raymond T White
Other companies: NN, Inc. (Director · Since at least Jan 16, 2026); Clear Channel Outdoor Holdings, Inc. (Director · Since at least Jan 31, 2024); Momentive Global Inc (Director · Mar 1, 2022 – May 31, 2023 · Past)
Director · Since at least Jan 9, 2023
All 47 people
PersonSeat
Richard Dean Hollis
Other companies: The Hain Celestial Group, Inc. (Director · Sep 27, 2017 – Nov 17, 2022 · Past); Diamond Foods Inc (Director · May 29, 2012 – Feb 29, 2016 · Past); Boulder Brands Inc (Director · Jul 5, 2011 – Jan 15, 2016 · Past)
Director · Jul 30, 2009 – Oct 14, 2015 · Past
Steven D Goldby
Other companies: Accelrys Inc (Director · Jul 1, 2010 – Aug 3, 2011 · Past); Sunesis Pharmaceuticals Inc (Director · Jun 19, 2006 – Jun 5, 2008 · Past); Symyx Technologies Inc (Director · Feb 15, 2006 – Jul 1, 2010 · Past)
Director · Dec 11, 2008 – May 23, 2019 · Past
Tonia L Pankopf
Other companies: WisdomTree, Inc. (Director · Since at least Jun 22, 2023); 180 Degree Capital Corp (Director · Aug 10, 2020 – Dec 31, 2021 · Past); Oxford Square Capital Corp. (Director · Jun 13, 2008 – Jun 13, 2008 · Past)
Director · Nov 13, 2012 – Jun 4, 2022 · Past
Albert D Bolles
Other companies: Arcadia Biosciences, Inc. (Director · May 12, 2018 – Aug 19, 2024 · Past); ConAgra Brands, Inc. (EVP & Chief Tech & Op Officer · Mar 14, 2014 – Jul 17, 2015 · Past)
Chief Executive Officer · May 8, 2014 – May 23, 2022 · Past
Fred Frank
Other companies: PDL BioPharma Inc (Director · Mar 11, 2009 – Jun 5, 2012 · Past); Pharmaceutical Product Development Inc (Director · Jan 3, 2006 – Dec 5, 2011 · Past)
Director · Jun 15, 2006 – Oct 14, 2020 · Past
Montgomery Molly
Other companies: Tigo Energy, Inc. (Director · Aug 5, 2021 – Aug 10, 2021 · Past); Reservoir Media, Inc.. (Director · Dec 10, 2020 – Dec 15, 2020 · Past)
Chief Executive Officer · Jun 22, 2009 – Jun 6, 2019 · Past
Patrick D Walsh
Other companies: ANI Pharmaceuticals, Inc. (Director · Since at least May 17, 2018); Avid Bioservices Inc (Director · Oct 20, 2017 – Dec 14, 2020 · Past)
Director · Oct 14, 2020 – Jun 4, 2021 · Past
Charles Macaluso
Other companies: Williams Industrial Services Group Inc (Director · Feb 4, 2021 – Feb 4, 2021 · Past)
Director · Oct 15, 2020 – Oct 15, 2020 · Past
Deborah D Carosella
Other companies: Arcadia Biosciences, Inc. (Director · Feb 22, 2021 – Aug 19, 2024 · Past)
Director · Mar 14, 2017 – Jun 4, 2022 · Past
Nathaniel Calloway
Other companies: Anebulo Pharmaceuticals, Inc. (Director · Oct 28, 2022 – Apr 4, 2025 · Past)
Director · Jan 9, 2023 – Jul 8, 2024 · Past
Ryan D. Lake
Other companies: Recro Pharma Inc (Chief Financial Officer · Jan 2, 2018 – Apr 8, 2024 · Past)
Chief Financial Officer · Since at least Sep 3, 2024
Brian F McLaughlinChief Financial Officer · Oct 16, 2019 – Oct 19, 2020 · Past
Damian A HajdukChief Scientific Officer · May 26, 2010 – May 24, 2013 · Past
David D TaftChief Operating Officer · Mar 27, 2006 – May 26, 2010 · Past
Dawn KimballChief People Officer · Oct 16, 2019 – Mar 12, 2021 · Past
Dennis J AllinghamExecutive Vice President · May 26, 2010 – May 30, 2013 · Past
Gary T SteeleDirector · Jan 17, 2006 – May 30, 2018 · Past
Gregory S SkinnerChief Financial Officer · Jun 15, 2006 – Jan 16, 2020 · Past
Humberto Calheiros AntunesDirector · Since at least Aug 15, 2024
Jackie KleckerExecutive Vice President, Quality and Development Services · Since at least Apr 22, 2025
James G HallChief Executive Officer, Director · Apr 14, 2021 – Jun 1, 2023 · Past
John D MorbergChief Financial Officer · Jan 18, 2021 – Jan 18, 2024 · Past
Lovas Katrina HoudeDirector · Since at least Aug 5, 2019
Mark DaFonsecaChief Commercial Officer · Since at least Oct 28, 2025
Nicholas TompkinsDirector · May 26, 2016 – Oct 20, 2016 · Past
Parker K JavidVice President · Jul 25, 2018 – Oct 17, 2019 · Past
Paul Harold JohnsonDirector · Since at least Aug 15, 2024
Paul JosephsChief Executive Officer · Since at least May 20, 2024
Raymond H DiradoorianDirector · Jan 20, 2022 – Jul 8, 2024 · Past
Robert TobinDirector · Jun 15, 2006 – Oct 16, 2019 · Past
Ronald Lane MidyettChief Operations Officer · Jan 7, 2008 – May 23, 2018 · Past
Stephen E HalprinDirector · May 16, 2012 – Sep 12, 2014 · Past
Steven P BitlerVice President, Technology · Mar 31, 2006 – May 23, 2018 · Past
Thomas D SalusChief Legal & Administration · Since at least Apr 14, 2025
Thomas GuldagerSr. Vice President, Operations · Since at least Jan 2, 2025
Timothy P BurgessSenior VP of Supply Chain · Jul 25, 2019 – Jul 27, 2021 · Past
Tom SalusChief Legal and Administration Officer · Since at least Apr 14, 2025

Open People

Log in to ask 6ix AI your own questions about Lifecore Biomedical, Inc.